Mid-regional pro-atrial natriuretic peptide and the assessment of volaemic status and differential diagnosis of profound hyponatraemia - PubMed (original) (raw)
Observational Study
doi: 10.1111/joim.12332. Epub 2014 Dec 11.
B Winzeler 1 2, I Suter-Widmer 1 2, P Schuetz 2 3, B Arici 1 2, M Bally 2 3, C A Blum 2 3, C H Nickel 2 4, R Bingisser 2 4, A Bock 2 5, K Rentsch Savoca 2 6, A Huber 2 7, B Müller 2 3, M Christ-Crain 1 2
Affiliations
- PMID: 25418365
- DOI: 10.1111/joim.12332
Free article
Observational Study
Mid-regional pro-atrial natriuretic peptide and the assessment of volaemic status and differential diagnosis of profound hyponatraemia
N Nigro et al. J Intern Med. 2015 Jul.
Free article
Abstract
Background: Hyponatraemia is common and its differential diagnosis and consequent therapy management is challenging. The differential diagnosis is mainly based on the routine clinical assessment of volume status, which is often misleading. Mid-regional pro-atrial natriuretic peptide (MR-proANP) is associated with extracellular and cardiac fluid volume.
Methods: A total of 227 consecutive patients admitted to the emergency department with profound hypo-osmolar hyponatraemia (Na < 125 mmol L(-1) ) were included in this prospective multicentre observational study conducted in two tertiary centres in Switzerland. A standardized diagnostic evaluation of the underlying cause of hyponatraemia was performed, and an expert panel carefully evaluated volaemic status using clinical criteria. MR-proANP levels were compared between patients with hyponatraemia of different aetiologies and for assessment of volume status.
Results: MR-proANP levels were higher in patients with hypervolaemic hyponatraemia compared to patients with hypovolaemic or euvolaemic hyponatraemia (P = 0.0002). The area under the curve (AUC) to predict an excess of extracellular fluid volume, compared to euvolaemia, was 0.73 [95% confidence interval (CI) 0.62-0.84]. Additionally, in multivariate analysis, MR-proANP remained an independent predictor of excess extracellular fluid volume after adjustment for congestive heart failure (P = 0.012). MR-proANP predicted the syndrome of inappropriate antidiuresis (SIAD) versus hypovolaemic and hypervolaemic hyponatraemia with an AUC of 0.77 (95% CI 0.69-0.84).
Conclusion: MR-proANP is associated with extracellular fluid volume in patients with hyponatraemia and remains an independent predictor of hypervolaemia after adjustment for congestive heart failure. MR-proANP may be a marker for discrimination between the SIAD and hypovolaemic or hypervolaemic hyponatraemia.
Keywords: mid-regional pro-atrial natriuretic peptide; profound hyponatraemia; volume status.
© 2014 The Association for the Publication of the Journal of Internal Medicine.
Similar articles
- Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J, Potocki M, Murray K, Breidthardt T, Ziller R, Mosimann T, Klima T, Hoeller R, Moehring B, Sou SM, Rubini Gimenez M, Morgenthaler NG, Mueller C. Eckstein J, et al. Heart. 2012 Oct;98(20):1518-22. doi: 10.1136/heartjnl-2012-302260. Epub 2012 Aug 3. Heart. 2012. PMID: 22865868 - Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. von Haehling S, et al. J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. doi: 10.1016/j.jacc.2007.08.012. Epub 2007 Oct 29. J Am Coll Cardiol. 2007. PMID: 17996563 - Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis.
Winzeler B, Lengsfeld S, Nigro N, Suter-Widmer I, Schütz P, Arici B, Bally M, Blum C, Bock A, Huber A, Müller B, Christ-Crain M. Winzeler B, et al. J Intern Med. 2016 Dec;280(6):609-617. doi: 10.1111/joim.12532. Epub 2016 Aug 1. J Intern Med. 2016. PMID: 27481546 - Diagnosis and management of hyponatraemia in hospitalised patients.
Reddy P, Mooradian AD. Reddy P, et al. Int J Clin Pract. 2009 Oct;63(10):1494-508. doi: 10.1111/j.1742-1241.2009.02103.x. Int J Clin Pract. 2009. PMID: 19769706 Review. - Natriuretic peptides in heart failure and acute coronary syndrome.
Gaggin HK, Januzzi JL Jr. Gaggin HK, et al. Clin Lab Med. 2014 Mar;34(1):43-58, vi. doi: 10.1016/j.cll.2013.11.007. Epub 2014 Jan 14. Clin Lab Med. 2014. PMID: 24507786 Review.
Cited by
- Screening and Analysis of Potential Critical Gene in Acute Myocardial Infarction Based on a miRNA-mRNA Regulatory Network.
Hou R, Guo D, Fan M, Hou Y, Zhao J, Wu X. Hou R, et al. Int J Gen Med. 2022 Mar 10;15:2847-2860. doi: 10.2147/IJGM.S354641. eCollection 2022. Int J Gen Med. 2022. PMID: 35300139 Free PMC article. - Association between copeptin levels and treatment responses to hypertonic saline infusion in patients with symptomatic hyponatremia: a prospective cohort study.
Go S, Kim S, Son HE, Ryu JY, Yang H, Choi SR, Seo JW, Jo YH, Koo JR, Baek SH. Go S, et al. Kidney Res Clin Pract. 2021 Sep;40(3):371-382. doi: 10.23876/j.krcp.20.233. Epub 2021 Jul 8. Kidney Res Clin Pract. 2021. PMID: 34233437 Free PMC article. - Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.
Hoorn EJ, Zietse R. Hoorn EJ, et al. J Am Soc Nephrol. 2017 May;28(5):1340-1349. doi: 10.1681/ASN.2016101139. Epub 2017 Feb 7. J Am Soc Nephrol. 2017. PMID: 28174217 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources